New Drugs & OTCs

05/16/2011 - 8:53am
Victrelis approved by FDA as chronic hepatitis C treatment

The Food and Drug Administration has approved a new treatment for chronic hepatitis C, the agency said Friday.

05/13/2011 - 2:55pm
Thinksport Livestrong sunscreen hits retail

In honor of Skin Cancer Awareness Month, Thinksport and Livestrong have announced that Thinksport Livestrong sunscreen now is available online and in stores just in time for summer.

05/13/2011 - 10:35am
PhRMA: More than 850 medicines in development for diseases that disproportionately affect women

More than 800 drugs are in development for diseases that affect women, according to a pharmaceutical industry lobbying group.

05/13/2011 - 10:14am
Mylan launches generic Risperdal M-Tab

Generic drug maker Mylan has launched a version of a drug used to treat schizophrenia, the company said Friday.

05/11/2011 - 11:37am
Genentech seeks regulatory approval for vemurafenib

Genentech is seeking approval for a new drug to treat skin cancer, the company said Wednesday.

05/10/2011 - 11:53am
Report: Number of drug approvals by FDA may increase

The Food and Drug Administration expects to approve an increasing number of drugs, according to published reports.

05/10/2011 - 11:19am
FDA OKs Sanofi Pasteur's Fluzone Intradermal

Sanofi’s vaccines division has won Food and Drug Administration approval for a vaccine designed for injection into the skin, the company said Tuesday.

05/10/2011 - 10:48am
Impax commences trial for investigational RLS treatment

The branded-drug division of Impax Labs plans to conduct early-stage clinical studies of an investigational drug for restless leg syndrome, the company said Tuesday.

05/09/2011 - 2:21pm
Mithridion's PSP treatment granted orphan drug designation

The Food and Drug Administration has granted orphan drug designation to a treatment made by Mithridion for a rare neurological disorder, Mithridion said Monday.

05/09/2011 - 10:12am
Impax confirms patent challenge for generic Concerta

Alza Corp. is attempting to block Impax Labs from developing a generic version of Alza's attention deficit hyperactivity disorder treatment.

© 2013 Drug Store News. All Rights Reserved.